These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 31068412)
1. The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland. Sveinsdóttir H; Björnsdóttir JB; Erlendsdóttir H; Hjálmarsdóttir MÁ; Hrafnkelsson B; Haraldsson Á; Kristinsson KG; Haraldsson G J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31068412 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial. Sáez-Llorens X; Rowley S; Wong D; Rodríguez M; Calvo A; Troitiño M; Salas A; Vega V; Castrejón MM; Lommel P; Pascal TG; Hausdorff WP; Borys D; Ruiz-Guiñazú J; Ortega-Barría E; Yarzabal JP; Schuerman L Hum Vaccin Immunother; 2017 Jun; 13(6):1-16. PubMed ID: 28368738 [TBL] [Abstract][Full Text] [Related]
3. Use of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) in an Australian Indigenous paediatric population does not alter the prevalence of nontypeable Haemophilus influenzae without the protein D gene. Beissbarth J; Smith-Vaughan HC; Harris TM; Binks MJ; Leach AJ Vaccine; 2019 Jul; 37(30):4089-4093. PubMed ID: 31164306 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland. Vesikari T; Forsten A; Seppä I; Kaijalainen T; Puumalainen T; Soininen A; Traskine M; Lommel P; Schoonbroodt S; Hezareh M; Moreira M; Borys D; Schuerman L J Pediatric Infect Dis Soc; 2016 Sep; 5(3):237-248. PubMed ID: 27125273 [TBL] [Abstract][Full Text] [Related]
5. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice. Michel LV; Kaur R; Zavorin M; Pryharski K; Khan MN; LaClair C; O'Neil M; Xu Q; Pichichero ME J Med Microbiol; 2018 Oct; 67(10):1527-1532. PubMed ID: 30136923 [TBL] [Abstract][Full Text] [Related]
6. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage. Clarke C; Bakaletz LO; Ruiz-Guiñazú J; Borys D; Mrkvan T Expert Rev Vaccines; 2017 Jul; 16(7):1-14. PubMed ID: 28571504 [TBL] [Abstract][Full Text] [Related]
7. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines. Leach AJ; Wigger C; Beissbarth J; Woltring D; Andrews R; Chatfield MD; Smith-Vaughan H; Morris PS Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():224-32. PubMed ID: 27260611 [TBL] [Abstract][Full Text] [Related]
8. Reduced nontypeable Haemophilus influenzae lower airway infection in children with chronic endobronchial suppuration vaccinated with the 10-valent pneumococcal H. influenzae protein D conjugate vaccine. Hare KM; Smith-Vaughan HC; Leach AJ; Pizzutto SJ; McCallum GB; Chang AB Vaccine; 2018 Mar; 36(13):1736-1742. PubMed ID: 29478754 [TBL] [Abstract][Full Text] [Related]
9. Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine. Leach AJ; Wigger C; Hare K; Hampton V; Beissbarth J; Andrews R; Chatfield M; Smith-Vaughan H; Morris PS BMC Pediatr; 2015 Oct; 15():162. PubMed ID: 26482232 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the indirect impact of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine in a cluster-randomised trial. Rinta-Kokko H; Palmu AA; Ruokokoski E; Nieminen H; Moreira M; Schuerman L; Borys D; Jokinen J PLoS One; 2022; 17(1):e0261750. PubMed ID: 34986178 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial. Tregnaghi MW; Sáez-Llorens X; López P; Abate H; Smith E; Pósleman A; Calvo A; Wong D; Cortes-Barbosa C; Ceballos A; Tregnaghi M; Sierra A; Rodriguez M; Troitiño M; Carabajal C; Falaschi A; Leandro A; Castrejón MM; Lepetic A; Lommel P; Hausdorff WP; Borys D; Ruiz Guiñazú J; Ortega-Barría E; Yarzábal JP; Schuerman L; PLoS Med; 2014 Jun; 11(6):e1001657. PubMed ID: 24892763 [TBL] [Abstract][Full Text] [Related]
12. Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+0 pneumococcal conjugate vaccine schedule. Wiertsema SP; Kirkham LA; Corscadden KJ; Mowe EN; Bowman JM; Jacoby P; Francis R; Vijayasekaran S; Coates HL; Riley TV; Richmond P Vaccine; 2011 Jul; 29(32):5163-70. PubMed ID: 21621576 [TBL] [Abstract][Full Text] [Related]
13. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age. Prymula R; Kriz P; Kaliskova E; Pascal T; Poolman J; Schuerman L Vaccine; 2009 Dec; 28(1):71-8. PubMed ID: 19818722 [TBL] [Abstract][Full Text] [Related]
14. Decreased Acute Otitis Media With Treatment Failure After Introduction of the Ten-valent Pneumococcal Haemophilus influenzae Protein D Conjugate Vaccine. Eythorsson E; Hrafnkelsson B; Erlendsdóttir H; Gudmundsson SA; Kristinsson KG; Haraldsson Á Pediatr Infect Dis J; 2018 Apr; 37(4):361-366. PubMed ID: 29278616 [TBL] [Abstract][Full Text] [Related]
15. Effect of Vaccination on Pneumococci Isolated from the Nasopharynx of Healthy Children and the Middle Ear of Children with Otitis Media in Iceland. Quirk SJ; Haraldsson G; Erlendsdóttir H; Hjálmarsdóttir MÁ; van Tonder AJ; Hrafnkelsson B; Sigurdsson S; Bentley SD; Haraldsson Á; Brueggemann AB; Kristinsson KG J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257906 [TBL] [Abstract][Full Text] [Related]
16. Carriage of Haemophilus influenzae among Brazilian children attending day care centers in the era of widespread Hib vaccination. de Carvalho CX; Kipnis A; Thörn L; de Andrade JG; Pimenta F; Brandileone MC; Zanella RC; Flannery B; Sgambatti S; Andrade AL Vaccine; 2011 Feb; 29(7):1438-42. PubMed ID: 21199703 [TBL] [Abstract][Full Text] [Related]
18. Changes in nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among healthy children attending a day-care centre before and after official financial support for the 7-valent pneumococcal conjugate vaccine and H. influenzae type b vaccine in Japan. Oikawa J; Ishiwada N; Takahashi Y; Hishiki H; Nagasawa K; Takahashi S; Watanabe M; Chang B; Kohno Y J Infect Chemother; 2014 Feb; 20(2):146-9. PubMed ID: 24582389 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Vesikari T; Wysocki J; Chevallier B; Karvonen A; Czajka H; Arsène JP; Lommel P; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S66-76. PubMed ID: 19325449 [TBL] [Abstract][Full Text] [Related]
20. Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan. Ubukata K; Morozumi M; Sakuma M; Adachi Y; Mokuno E; Tajima T; Iwata S; J Infect Chemother; 2019 Sep; 25(9):720-726. PubMed ID: 30987951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]